This is a test category
Genomic Landscape of Malignant Mesotheliomas
Molecular Cancer Therapeutics 2016 August 9 [Epub ahead of print] [Link] Kato S, Tomson BN, Buys TP, Elkin SK, Carter JL, Kurzrock R Abstract Understanding the genomic landscape of malignant mesothelioma may identify novel molecular drivers of this ultra-rare disease, which can lead to an expanded roster of targeted therapies and clinical trial options for…
Read MoreMicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients
Genomics Data 2016 June 20 [Link] Lin RC, Kirschner MB, Cheng YY, van Zandwijk N, Reid G Abstract Malignant pleural mesothelioma (MPM) is a tumor originating in the mesothelium, the membrane lining the thoracic cavities, and is induced by exposure to asbestos. Australia suffers one of the world’s highest rates of MPM and the incidence…
Read MorePain in Malignant Pleural Mesothelioma: A Prospective Characterization Study
Pain Med 2016 April 26 [Epub ahead of print] [Link] MacLeod N, Kelly C, Stobo J, McMahon L, Taggart D, Fallon M, Laird BJ. Abstract NTRODUCTION: Malignant pleural mesothelioma (MPM) is associated with severe pain. The underlying neurobiology of this is complex. The primary aim of this study was to characterize pain in MPM. METHODS:…
Read More